Jan 31, 2018 21:05 pm UTC| Business
PHOENIX, Jan. 31, 2018 -- Cavco Industries, Inc. (Nasdaq:CVCO) will release earnings for the third quarter of fiscal year 2018 on Tuesday, February 6, 2018 after the close of market. Senior management will discuss the...
EFI Reports Record Revenue for Fourth Quarter and Full Year 2017
Jan 31, 2018 21:05 pm UTC| Business
FREMONT, Calif., Jan. 31, 2018 -- Electronics For Imaging, Inc. (Nasdaq:EFII), a world leader in customer-focused digital printing innovation, today announced its results for the fourth quarter and year ended December...
Wheeler Real Estate Investment Trust, Inc. Names Matthew Reddy as Chief Financial Officer
Jan 31, 2018 21:05 pm UTC| Business
VIRGINIA BEACH, Va., Jan. 31, 2018 -- Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) (“Wheeler” or the “Company”), a fully-integrated, self-managed commercial real estate investment company focused on...
Black Knight to Present at the Goldman Sachs Technology and Internet Conference
Jan 31, 2018 21:05 pm UTC| Business
JACKSONVILLE, Fla., Jan. 31, 2018 -- Black Knight, Inc. (NYSE:BKI), a leading provider of software, data and analytics solutions to the mortgage and consumer loan, real estate and capital markets verticals, today...
Kimball International, Inc. Reports Second Quarter Fiscal Year 2018 Results
Jan 31, 2018 21:05 pm UTC| Business
JASPER, Ind., Jan. 31, 2018 -- Kimball International, Inc. (NASDAQ:KBAL) today announced the following results for the quarter ended December 31, 2017: Revenue was $173.7 million, a 2% increase over the prior year...
Voyager Therapeutics Announces CEO Succession Plan for 2018
Jan 31, 2018 21:05 pm UTC| Business
CAMBRIDGE, Mass., Jan. 31, 2018 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases today announced plans...
Zogenix Completes Enrollment in Second ZX008 Phase 3 Clinical Trial in Dravet Syndrome
Jan 31, 2018 21:05 pm UTC| Business
Study 1504 Top-Line Data on Track for 2Q 2018 EMERYVILLE, Calif., Jan. 31, 2018 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS)...